Package 0003-3638-10

{"route": ["ORAL"], "spl_id": "510c2d51-4943-401c-a008-ea22f61c6938", "openfda": {"upc": ["0300033624120", "0300033622126"], "unii": ["4MT4VIE29P"], "rxcui": ["402093", "402094", "402246", "402247", "664741", "664743", "1598985", "1598989"], "spl_set_id": ["165cff62-b284-4a27-a65d-9ec8a5bfcdd8"], "manufacturer_name": ["E.R. Squibb & Sons, L.L.C."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 PACKET in 1 CARTON (0003-3638-10)  / 1 POWDER in 1 PACKET", "package_ndc": "0003-3638-10", "marketing_start_date": "20141219"}], "brand_name": "REYATAZ", "product_id": "0003-3638_510c2d51-4943-401c-a008-ea22f61c6938", "dosage_form": "POWDER", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "Protease Inhibitor [EPC]", "UDP Glucuronosyltransferases Inhibitors [MoA]", "UGT1A1 Inhibitors [MoA]"], "product_ndc": "0003-3638", "generic_name": "ATAZANAVIR", "labeler_name": "E.R. Squibb & Sons, L.L.C.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "REYATAZ", "active_ingredients": [{"name": "ATAZANAVIR SULFATE", "strength": "50 mg/1"}], "application_number": "NDA206352", "marketing_category": "NDA", "marketing_start_date": "20141219", "listing_expiration_date": "20261231"}